Furthermore, the genetic profile of the two different sections from Patient #1 (Tumors #1 and #2) indicate that Tumor #1 may have clonally evolved from Tumor #2 by acquiring mutations in the PI3K pathway, which supports the relevance of the mutations in this pathway during the progression of this malignancy. The gene discussed is PIK3CA; the disease is neoplasm.